Ronald G. Gelbman, Director at HAEMONETICS CORP (HAE), sold 5,840 shares at $56.57 ($331K) on 2017-11-16, disclosed to the SEC on 2017-11-17.
Open-market sale of $331k HAE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $56.57 | 65 | $4K | 1.1% |
| 2 | $56.58 | 235 | $13K | 4.0% |
| 3 | $56.60 | 200 | $11K | 3.4% |
| 4 | $56.62 | 240 | $14K | 4.1% |
| 5 | $56.63 | 200 | $11K | 3.4% |
| 6 | $56.65 | 400 |
| $23K |
| 6.8% |
| 7 | $56.66 | 100 | $6K | 1.7% |
| 8 | $56.66 | 100 | $6K | 1.7% |
| 9 | $56.67 | 300 | $17K | 5.1% |
| 10 | $56.67 | 100 | $6K | 1.7% |
| 11 | $56.68 | 300 | $17K | 5.1% |
| 12 | $56.69 | 400 | $23K | 6.8% |
| 13 | $56.70 | 1,200 | $68K | 20.6% |
| 14 | $56.71 | 100 | $6K | 1.7% |
| 15 | $56.72 | 100 | $6K | 1.7% |
| 16 | $56.73 | 400 | $23K | 6.9% |
| 17 | $56.73 | 300 | $17K | 5.1% |
| 18 | $56.74 | 300 | $17K | 5.1% |
| 19 | $56.77 | 300 | $17K | 5.1% |
| 20 | $56.78 | 200 | $11K | 3.4% |
| 21 | $56.80 | 300 | $17K | 5.1% |
| Total | $56.69 avg | 5,840 | $331K | 100% |
| Filing → |
| HAE | SELL | 2019-02-19 | $1.4M | — | Filing → |
| HAE | SELL | 2018-12-18 | $892K | — | Filing → |
| HAE | SELL | 2017-04-27 | $343K | — | Filing → |